Prospective observational study of medication reviews in internal medicine wards: evaluation of drug-related problems.

European Journal of Hospital Pharmacy. Science and Practice
Lina HellströmAsa Bondesson

Abstract

The Lund Integrated Medicines Management model offers a systematic approach for individualising and optimising patient drug treatment. Clinical, economical and humanistic outcomes have been shown as well as results from the medication reconciliation process. There is a need also to describe the medication review process. To describe the frequency and types of drug-related problems (DRPs) identified during medication reviews and to evaluate the actions of the pharmacists and the physicians regarding the identified DRPs. Structured medication reviews were conducted by a multi-professional team on top of standard care for 719 patients in two internal medicine wards in a Swedish University Hospital. The medication reviews were studied retrospectively to classify DRPs and actions taken. A total of 573 (80%) of patients had at least one actual DRP; an average of three DRPs per patient and in total 2164. Wrong drug and adverse drug reaction were the most common types of DRPs. The most frequent medication groups involved in DRPs were drugs for the cardiovascular system and the nervous system and the most frequent substances were warfarin, digoxin, furosemide and paracetamol. The 10 most common medications accounted for 27% of the actua...Continue Reading

References

Oct 1, 1991·Medical Care·L A BeroJ A Bird
Nov 1, 1990·DICP : the Annals of Pharmacotherapy·L M StrandG D Lamsam
Jul 1, 1993·The Annals of Pharmacotherapy·T R Einarson
Apr 29, 1998·JAMA : the Journal of the American Medical Association·J LazarouP N Corey
Jun 28, 2002·The Annals of Pharmacotherapy·Almut G WintersteinCharles Poole
Nov 30, 2004·European Journal of Clinical Pharmacology·Hege Salvesen BlixElspeth K Walseth
Feb 15, 2011·European Journal of Clinical Pharmacology·Lina M HellströmTommy Eriksson
Nov 15, 2011·International Journal of Clinical Pharmacy·Anna Bergkvist ChristensenTommy Eriksson
Jan 19, 2012·International Journal of Clinical Pharmacy·Asa BondessonTommy Eriksson
Apr 5, 2012·BMC Clinical Pharmacology·Lina M HellströmTommy Eriksson
Sep 8, 2012·European Journal of Clinical Pharmacology·Asa BondessonPeter Höglund
Jan 1, 2012·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Fabio SalviAntonio Cherubini
Oct 11, 2014·Journal of Clinical Pharmacy and Therapeutics·P BedouchUNKNOWN French Society of Clinical Pharmacy's Act-IP© Group
May 4, 2018·Basic & Clinical Pharmacology & Toxicology·Helene Skjøt-ArkilTrine Graabaek
Nov 6, 2018·Research in Social & Administrative Pharmacy : RSAP·Dalia M DawoudJulian Bion
Dec 21, 2019·Bulletin of Emergency & Trauma·Mohammed Biset AyalewOusman Abubeker Abdela

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Risk Reduction

Prevention of cardiovascular disease is an important health initiative. Risk reduction including physical activity, smoking cessation, diet, blood pressure lowering drugs and pharmacotherapy. Here is the latest research on cardiovascular risk reduction.